PubMed中文版
| PubMed ID | 31564456 |
|---|---|
| 发表日期 | 2019 Oct 3 |
| 作者 | Long JM Holtzman DM |
| 文献标题 | Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. |
| 原始出处 | Cell |
| 影响因子 | 42.5 期刊引文指标 7.99 |
| PubMed ID | 39283851 |
|---|---|
| 发表日期 | 2024 Sep |
| 作者 | Jaqua EE Tran MN Hanna M |
| 文献标题 | Alzheimer Disease: Treatment of Cognitive and Functional Symptoms. |
| 原始出处 | American family physician |
| 影响因子 | 3.5 期刊引文指标 1.63 |
| PubMed ID | 36749830 |
|---|---|
| 发表日期 | 2023 Feb |
| 作者 | Vitek GE Decourt B Sabbagh MN |
| 文献标题 | Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease. |
| 原始出处 | Expert opinion on investigational drugs |
| 影响因子 | 4.1 期刊引文指标 0.96 |
| PubMed ID | 39653749 |
|---|---|
| 发表日期 | 2025 May |
| 作者 | Heneka MT van der Flier WM Jessen F Hoozemanns J Thal DR Boche D Brosseron F Teunissen C Zetterberg H Jacobs AH Edison P Ramirez A Cruchaga C Lambert JC Laza AR Sanchez-Mut JV Fischer A Castro-Gomez S Stein TD Kleineidam L Wagner M Neher JJ Cunningham C Singhrao SK Prinz M Glass CK Schlachetzki JCM Butovsky O Kleemann K De Jaeger PL Scheiblich H Brown GC Landreth G Moutinho M Grutzendler J Gomez-Nicola D McManus RM Andreasson K Ising C Karabag D Baker DJ Liddelow SA Verkhratsky A Tansey M Monsonego A Aigner L Dorothée G Nave KA Simons M Constantin G Rosenzweig N Pascual A Petzold GC Kipnis J Venegas C Colonna M Walter J Tenner AJ O'Banion MK Steinert JR Feinstein DL Sastre M Bhaskar K Hong S Schafer DP Golde T Ransohoff RM Morgan D Breitner J Mancuso R Riechers SP |
| 文献标题 | Neuroinflammation in Alzheimer disease. |
| 原始出处 | Nature reviews. Immunology |
| 影响因子 | 60.9 期刊引文指标 7.86 |
| PubMed ID | 30846383 |
|---|---|
| 发表日期 | 2019 May |
| 作者 | Dewey CW Davies ES Xie H Wakshlag JJ |
| 文献标题 | Canine Cognitive Dysfunction: Pathophysiology, Diagnosis, and Treatment. |
| 原始出处 | The Veterinary clinics of North America. Small animal practice |
| 影响因子 | 2 期刊引文指标 1.01 |
| PubMed ID | 37667136 |
|---|---|
| 发表日期 | 2023 Sep |
| 作者 | Self WK Holtzman DM |
| 文献标题 | Emerging diagnostics and therapeutics for Alzheimer disease. |
| 原始出处 | Nature medicine |
| 影响因子 | 50 期刊引文指标 11.03 |
| PubMed ID | 36251300 |
|---|---|
| 发表日期 | 2022 Dec 1 |
| 作者 | Pontecorvo MJ Lu M Burnham SC Schade AE Dage JL Shcherbinin S Collins EC Sims JR Mintun MA |
| 文献标题 | Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial. |
| 原始出处 | JAMA neurology |
| 影响因子 | 21.3 期刊引文指标 6.16 |
| PubMed ID | 38095619 |
|---|---|
| 发表日期 | 2024 Oct |
| 作者 | Park J Simpson C Patel K |
| 文献标题 | Lecanemab: A Humanized Monoclonal Antibody for the Treatment of Early Alzheimer Disease. |
| 原始出处 | The Annals of pharmacotherapy |
| 影响因子 | 2.3 期刊引文指标 0.48 |
| PubMed ID | 38424470 |
|---|---|
| 发表日期 | 2024 Jun |
| 作者 | Mary A Mancuso R Heneka MT |
| 文献标题 | Immune Activation in Alzheimer Disease. |
| 原始出处 | Annual review of immunology |
| 影响因子 | 33.3 期刊引文指标 3.64 |
| PubMed ID | 32840331 |
|---|---|
| 发表日期 | 2020 Aug |
| 作者 | Wong W |
| 文献标题 | Economic burden of Alzheimer disease and managed care considerations. |
| 原始出处 | The American journal of managed care |
| 影响因子 | 2.1 期刊引文指标 0.67 |
| PubMed ID | 31643956 |
|---|---|
| 发表日期 | 2012 |
| 作者 | |
| 文献标题 | Alzheimer Disease Agents. |
| 原始出处 | |
| 影响因子 |
| PubMed ID | 39620843 |
|---|---|
| 发表日期 | 2024 Dec 1 |
| 作者 | Risacher SL |
| 文献标题 | Neuroimaging in Dementia. |
| 原始出处 | Continuum (Minneapolis, Minn.) |
| 影响因子 |
| PubMed ID | 21671540 |
|---|---|
| 发表日期 | 2011 Jun 15 |
| 作者 | Winslow BT Onysko MK Stob CM Hazlewood KA |
| 文献标题 | Treatment of Alzheimer disease. |
| 原始出处 | American family physician |
| 影响因子 | 3.5 期刊引文指标 1.63 |
| PubMed ID | 24549548 |
|---|---|
| 发表日期 | 2014 Feb 19 |
| 作者 | Porsteinsson AP Drye LT Pollock BG Devanand DP Frangakis C Ismail Z Marano C Meinert CL Mintzer JE Munro CA Pelton G Rabins PV Rosenberg PB Schneider LS Shade DM Weintraub D Yesavage J Lyketsos CG CitAD Research Group |
| 文献标题 | Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. |
| 原始出处 | JAMA |
| 影响因子 | 55 期刊引文指标 11.47 |
| PubMed ID | 30020629 |
|---|---|
| 发表日期 | 2025 Jan |
| 作者 | Kumar A Gupta V Sharma S |
| 文献标题 | Donepezil. |
| 原始出处 | |
| 影响因子 |
| PubMed ID | 36197131 |
|---|---|
| 发表日期 | 2022 Sep |
| 作者 | Hill AM |
| 文献标题 | Alzheimer disease and the evolving treatment landscape. |
| 原始出处 | The American journal of managed care |
| 影响因子 | 2.1 期刊引文指标 0.67 |
| PubMed ID | 25551862 |
|---|---|
| 发表日期 | 2015 Jan-Mar |
| 作者 | Liang L Wei H |
| 文献标题 | Dantrolene, a treatment for Alzheimer disease? |
| 原始出处 | Alzheimer disease and associated disorders |
| 影响因子 | 1.4 期刊引文指标 0.6 |
| PubMed ID | 34662060 |
|---|---|
| 发表日期 | 2025 Jan |
| 作者 | Kalola UK Patel P Nguyen H |
| 文献标题 | Galantamine. |
| 原始出处 | |
| 影响因子 |
| PubMed ID | 35921507 |
|---|---|
| 发表日期 | 2022 Aug 1 |
| 作者 | Burke AD Goldfarb D |
| 文献标题 | Facilitating Treatment Initiation in Early-Stage Alzheimer Disease. |
| 原始出处 | The Journal of clinical psychiatry |
| 影响因子 | 4.6 期刊引文指标 1.25 |